Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2019; 19(4):295-298,313
DOI: 10.5428/pcar20190415
Analysis of treatment strategy for a case of carbapenem-resistant Klebsiella pneumoniae pneumonia and urinary tract infection in an elderly patient with stroke
1. WANG Xiaoying(Department of Pharmacy,Beijing Electric Power Hospital of State Grid Co. of China,Electric Power Teaching Hospital of Capital Medical University,Beijing 100073,China phoebejasmine@sina.com)
2. LIN Zhaohui(Department of Pharmacy,Beijing Electric Power Hospital of State Grid Co. of China,Electric Power Teaching Hospital of Capital Medical University,Beijing 100073,China )
3. XING Baiqian(Department of Pharmacy,Beijing Electric Power Hospital of State Grid Co. of China,Electric Power Teaching Hospital of Capital Medical University,Beijing 100073,China )
4. LI Zhongdong(Department of Pharmacy,Beijing Electric Power Hospital of State Grid Co. of China,Electric Power Teaching Hospital of Capital Medical University,Beijing 100073,China zhdl009@126.com)
ABSTRACT  Objective: To analyze the treatment process of a case of community-acquired pneumonia,suspicious staphylococcalemia,carbapenem-resistant Klebsiella pneumoniae (CRKP) pneumonia and urinary tract infection of an elderly patient with stroke,so as to provide reference for the treatment of similar cases.Methods: Clinical pharmacists were involved in several medical consultations. In accordance with the patient clinical manifestation, results of bacterial epidemiologic monitoring, as well as results of bacterial culture and drug testing, meropenem and fosfomycin combined with minocycline were used in treatment of the patient. Results and Conclusion: The clinical physicians developed the treatment regimen based on the advice of the clinical pharmacists, and as a result, good anti-infective effects were achieved, and the patient was cured.
Welcome to PCAR! You are the number 87 reader of this article!
Please cite this article as:
WANG Xiaoying,LIN Zhaohui,XING Baiqian,LI Zhongdong,. Analysis of treatment strategy for a case of carbapenem-resistant Klebsiella pneumoniae pneumonia and urinary tract infection in an elderly patient with stroke[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2019; 19(4): 295-298,313.
References:
1. Group of Chinese Expert Consensus on Diagnosis and Treatment of Stroke-related Pneumonia.Chinese expert consensus on diagnosis and treatment of stroke-related pneumonia[J].Chin J Intern Med,2010,49(12):1075-1078.In Chinese.
2. Chinese Thoracic Society.Guidelines for the diagnosis and treatment of adult community-acquired pneumonia(2016 ed)[J].Chin J Tuberc Respir Dis,2016,39(4):253-279.In Chinese.
3. Kalil A C,Metersky M L,Klompas M,et al.Management of adults with hospital-acquired and ventilator-associated pneumonia:2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society[J].Clin Infect Dis,2016,63(5):e61-e111.
4. HU Fupin,GUO Yan,ZHU Demei,et al.CHINET surveillance of bacterial resistance across China:report of the results in 2016[J].Chin J Infect Chemother,2017,17(5):481-491.In Chinese with English abstract.
5. SU Aimei,WEI Shaochun.Biliary pathogenic distribution and drug resistance in patients with biliary diseases[J].Chin J Exp Clin Infect Dis(Elect ed),2017,11(6):607-612.In Chinese with English abstract.
6. Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[M].28th ed.USA:Clinical and Laboratory Standards Institute,2018:34-35.
7. Chinese XDR Consensus Working Group,Guan X,He L,et al.Laboratory diagnosis,clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli:a Chinese consensus statement[J].Clin Microbiol Infect,2016,22(S1):S15-S25.
8. LIU Maochang,GE Miaomiao,CHEN Yujun,et al.A meta-analysis of the efficacy and safety of meropenem with imipenem plus cilastatin in the treatment of severe infections[J].Chin J Antibiot,2014,39(10):785-790.In Chinese with English abstract.
9. Committee of Experts on Rational Drug Use,Ministry of Health of Republic of China.China pharmaceutical reference[M].Chongqing:Chongqing Publishing Group,Chongqing Publishing House,2009:128-130.In Chinese.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口